Codes / ICD10CM / M1A.49X1

M1A.49X1 Other secondary chronic gout, multiple sites, with tophus (tophi)

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other Secondary Chronic Gout, Multiple Sites, With Tophus (Tophi)

Summary

Other secondary chronic gout, multiple sites, with tophus (tophi) is a form of arthritis resulting from elevated uric acid levels due to an identifiable underlying condition, leading to recurrent joint inflammation and tissue damage. It is characterized by persistent symptoms and the presence of tophi (urate crystal deposits) in multiple joints or tissues. The term "multiple sites" indicates the condition affects more than one joint or area, while "with tophus" specifies the presence of these deposits.

Causes

Other secondary chronic gout, multiple sites, with tophus arises from an underlying condition that disrupts uric acid metabolism, causing accumulation in the blood. This can stem from overproduction of uric acid or reduced renal clearance due to factors like chronic kidney disease, certain medications, or hematologic disorders. Over time, urate crystals deposit in multiple joints and tissues, triggering inflammation and forming tophi.

Risk Factors

  • Underlying conditions that affect uric acid metabolism (e.g., certain hematologic disorders, enzyme deficiencies)
  • Medications that increase uric acid levels (e.g., some diuretics, chemotherapy agents)
  • Chronic kidney disease or renal impairment
  • History of gout or hyperuricemia
  • Exposure to substances that disrupt uric acid excretion

Symptoms

  • Recurrent episodes of intense joint pain, often in the big toe, ankles, or knees
  • Persistent swelling, redness, and warmth in affected joints
  • Formation of tophi (hard, painless lumps) under the skin
  • Stiffness and limited joint mobility
  • Flare-ups triggered by stress, diet, or illness

Diagnosis

Diagnosis involves a combination of clinical evaluation, patient history, and laboratory tests. Joint fluid analysis may reveal urate crystals, and imaging (e.g., X-rays, ultrasound) can show tophi or joint damage. Blood tests assess uric acid levels and rule out underlying conditions. The presence of tophi and multiple affected sites supports the diagnosis.

Treatment Options

Treatment focuses on managing uric acid levels, reducing inflammation, and addressing underlying causes. Medications may include urate-lowering agents (e.g., allopurinol), anti-inflammatory drugs, or colchicine. Lifestyle modifications, such as dietary changes and hydration, are often recommended. In severe cases, surgery may be needed to remove tophi or repair joint damage.

Prognosis and Follow-Up

With proper management, symptoms can be controlled, and tophi may shrink or disappear. However, untreated or poorly managed cases can lead to joint damage and disability. Regular follow-up is essential to monitor uric acid levels, adjust treatment, and address complications. Long-term adherence to therapy improves outcomes.

Complications

  • Chronic joint damage or deformity
  • Kidney stones or renal impairment
  • Persistent tophi leading to functional impairment
  • Increased risk of cardiovascular disease
  • Reduced quality of life due to pain and mobility issues

Lifestyle & Prevention

  • Limit alcohol and high-purine foods (e.g., red meat, seafood)
  • Maintain a healthy weight and stay hydrated
  • Avoid medications that raise uric acid levels when possible
  • Follow prescribed treatment plans consistently
  • Manage underlying conditions (e.g., kidney disease) to reduce uric acid buildup

When to Seek Professional Help

Seek medical attention if you experience severe joint pain, swelling, or redness, especially if accompanied by fever or tophi. Prompt care is needed to prevent complications and adjust treatment. Consult a healthcare provider for persistent symptoms or flare-ups.

Tips for Medical Coders

Document the presence of tophi and the involvement of multiple sites to support the code M1A.49X1. Ensure underlying causes are clearly identified, as secondary gout requires a link to a specific condition. Use clinical notes to confirm the chronic nature and tophi formation, as these are key to accurate coding.

Book a walkthrough

M1A.49X1 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.